Northern Trust Corp Karyopharm Therapeutics Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 229,668 shares of KPTI stock, worth $165,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
229,668
Previous 870,167 73.61%
Holding current value
$165,360
Previous $757,000 74.9%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.7 - $1.06 $448,349 - $678,928
-640,499 Reduced 73.61%
229,668 $190,000
Q2 2024

Aug 14, 2024
SELL
$0.87 - $1.58 $77,115 - $140,048
-88,638 Reduced 9.24%
870,167 $757,000
Q1 2024

May 14, 2024
SELL
$0.72 - $1.66 $26,886 - $61,987
-37,342 Reduced 3.75%
958,805 $1.45 Million
Q4 2023

Feb 13, 2024
BUY
$0.68 - $1.31 $7,082 - $13,643
10,415 Added 1.06%
996,147 $856,000
Q3 2023

Nov 13, 2023
SELL
$1.14 - $1.81 $95,032 - $150,885
-83,362 Reduced 7.8%
985,732 $1.32 Million
Q2 2023

Aug 11, 2023
BUY
$1.79 - $4.59 $437,377 - $1.12 Million
244,345 Added 29.63%
1,069,094 $1.91 Million
Q1 2023

May 15, 2023
BUY
$2.84 - $3.92 $224,405 - $309,742
79,016 Added 10.6%
824,749 $3.21 Million
Q4 2022

Feb 13, 2023
SELL
$2.48 - $5.93 $19,954 - $47,712
-8,046 Reduced 1.07%
745,733 $2.54 Million
Q3 2022

Nov 14, 2022
SELL
$4.08 - $5.82 $58,421 - $83,336
-14,319 Reduced 1.86%
753,779 $4.12 Million
Q2 2022

Aug 12, 2022
BUY
$4.15 - $8.37 $15,616 - $31,496
3,763 Added 0.49%
768,098 $3.46 Million
Q1 2022

May 13, 2022
SELL
$5.91 - $14.38 $66,286 - $161,286
-11,216 Reduced 1.45%
764,335 $5.63 Million
Q4 2021

Feb 08, 2022
BUY
$5.21 - $8.61 $44,238 - $73,107
8,491 Added 1.11%
775,551 $4.99 Million
Q3 2021

Nov 15, 2021
SELL
$4.45 - $10.63 $81,087 - $193,699
-18,222 Reduced 2.32%
767,060 $4.46 Million
Q2 2021

Aug 13, 2021
BUY
$8.11 - $11.11 $326,395 - $447,133
40,246 Added 5.4%
785,282 $8.11 Million
Q1 2021

May 12, 2021
SELL
$9.85 - $17.69 $352,787 - $633,585
-35,816 Reduced 4.59%
745,036 $7.84 Million
Q4 2020

Feb 11, 2021
SELL
$14.15 - $17.19 $1 Million - $1.22 Million
-70,875 Reduced 8.32%
780,852 $12.1 Million
Q3 2020

Nov 16, 2020
SELL
$14.14 - $19.71 $719,358 - $1 Million
-50,874 Reduced 5.64%
851,727 $12.4 Million
Q2 2020

Aug 14, 2020
BUY
$16.6 - $25.25 $2.28 Million - $3.47 Million
137,274 Added 17.94%
902,601 $17.1 Million
Q1 2020

May 14, 2020
BUY
$14.38 - $27.72 $397,103 - $765,487
27,615 Added 3.74%
765,327 $14.7 Million
Q4 2019

Feb 14, 2020
SELL
$9.23 - $19.67 $38,489 - $82,023
-4,170 Reduced 0.56%
737,712 $14.1 Million
Q3 2019

Nov 13, 2019
BUY
$5.66 - $11.85 $719,487 - $1.51 Million
127,118 Added 20.68%
741,882 $7.14 Million
Q2 2019

Aug 13, 2019
BUY
$4.32 - $6.43 $51,909 - $77,262
12,016 Added 1.99%
614,764 $3.68 Million
Q1 2019

May 13, 2019
SELL
$4.12 - $10.25 $23,199 - $57,717
-5,631 Reduced 0.93%
602,748 $3.52 Million
Q4 2018

Feb 12, 2019
SELL
$8.2 - $16.95 $109,453 - $226,248
-13,348 Reduced 2.15%
608,379 $5.7 Million
Q3 2018

Nov 14, 2018
BUY
$17.03 - $21.18 $336,393 - $418,368
19,753 Added 3.28%
621,727 $10.6 Million
Q2 2018

Sep 18, 2018
BUY
$12.0 - $19.88 $8,952 - $14,830
746 Added 0.12%
601,974 $10.2 Million
Q2 2018

Aug 14, 2018
BUY
$12.0 - $19.88 $2.45 Million - $4.05 Million
203,934 Added 51.33%
601,228 $10.2 Million
Q1 2018

May 09, 2018
BUY
$9.92 - $17.25 $114,843 - $199,703
11,577 Added 3.0%
397,294 $5.33 Million
Q4 2017

Feb 14, 2018
SELL
$9.15 - $11.99 $279,212 - $365,874
-30,515 Reduced 7.33%
385,717 $3.7 Million
Q3 2017

Nov 13, 2017
BUY
$8.15 - $11.16 $3.39 Million - $4.65 Million
416,232
416,232 $4.57 Million

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $57.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email